Matthew Mishan covers medical products and life science tools. Mr. Mishan is seeing a modest inflection in growth particularly on the U.S. side for medical devices. He says strength on the medical device side should continue into 2016 and 2017. He says companies are showing that their products have clinical and economic value, which is making it a much easier sell for the hospitals. He talks about specific companies he likes and why.
Spinoff Medical Technology Stock Makes Top Pick for Matthew Mishan at KeyBanc
July 22, 2019
Interview Highlights: Donald Hooker of KeyBanc Capital Markets on Health Care IT
November 01, 2016
Interview Highlights: Sung Ji Nam of Avondale Partners on Medical Devices
August 03, 2016
Interview Highlights: Vijay Kumar of Evercore ISI on Medical Devices
August 03, 2016
Interview Highlights: Liana Moussatos of Wedbush Securities on Medical Research, Diagnostic Substances & Life Science Tools
October 28, 2016
